AXSM 98.19 (+3.79%)
US05464T1043BiotechnologyBiotechnology

Axsome Therapeutics (AXSM) Competitor Comparison

We are evaluating the key criteria listed to compare Axsome Therapeutics (AXSM) against its competitors in the Biotechnology industry.

Dividend yield - AXSM ranking 0 / 6

These are the competitors of Axsome Therapeutics in the industry Biotechnology ranked by dividend yield
1. Catalyst Biosciences CBIO
792.92
2. Merrimack Pharmaceuticals MACK
100
3. XOMA XOMA
6.69
4. Royalty Pharma RPRX
3.17
5. Comp SBS
1.67
6. Bio-Techne TECH
0.42

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.